Study aid, not legal advice. caselaw is not a law firm and does not provide legal advice or engage in the unauthorized practice of law (UPL). All briefs, outlines, and citation tools on these pages are educational summaries for law students; they are not a substitute for advice from a licensed attorney admitted in your jurisdiction. Bar-admission rules vary by state. For court filings or client matters, verify every authority against the official reporter and your court's local rules. Use of caselaw does not create an attorney-client relationship.
Eli Lilly & Co. v. Sav-on-Drugs, Inc., 1960 — 364 U.S. 860 · caselaw · US
General
Eli Lilly & Co. v. Sav-on-Drugs, Inc.
364 U.S. 860·Supreme Court of the United States·1960
Brief incoming
Hand-reviewed Bluebook brief (procedural posture, facts, issue, holding, reasoning, dissent) ships once the AI generation pipeline runs through this case. Join the waitlist to get notified when 1L briefs go live.
Opinion
No. 203.
Eli Lilly & Co. v. Sav-on-Drugs, Inc.
Joseph H. Stamler, Melvin P. Antell and Everett I. Willis for appellant. Vincent P. Biunno and Samuel M. Lane for appellee. David D. Furman, Attorney General of New Jersey, and Murry Brochin, Deputy Attorney General, for the State of New Jersey, intervenor-appellee, urging affirmance.
[MAJORITY]
Appeal from the Supreme Court of New Jersey. Probable jurisdiction noted.